Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Seitz

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Oncology|January 11, 2008
Cost consequences of adjuvant capecitabine, Mayo Clinic and de Gramont regimens for stage III colon cancer in the French settingJ Y Douillard, P Tilleul, M Ychou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Ondansetron Delayed Emesis Study GroupI Olver, W Paska, A Depierre, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 30, 2011
Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancerX B D'Journo, M Ouattara, A Loundou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancerM Ducreux, M Ychou, J F Seitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2011
Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacyC Twelves, W Scheithauer, J McKendrick, et al.
Endoscopy|October 26, 1999
Distant lymph node metastases in esophageal cancer: impact of endoscopic ultrasound-guided biopsyM Giovannini, G Monges, J F Seitz, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
Impact of UFT on tumoral TS and DPD levels in colorectal cancerG Bastian, J F Seitz, V Moutardier, et al.
Journal of Molecular Endocrinology|October 1, 1993
Detection of gastrin mRNA in fresh human colonic carcinomas by reverse transcription-polymerase chain reactionG Monges, P Biagini, J F Cantaloube, et al.
Cancer|March 15, 1997
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)C Tournigand, C Louvet, A de Gramont, et al.
Acta Gastroenterologica Latinoamericana|May 29, 1999
[Ecoendoscopy in the assessment of esophageal neoplasms]A Giacoia, P Thomas, M Giovannini, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Oncology|January 11, 2008
Cost consequences of adjuvant capecitabine, Mayo Clinic and de Gramont regimens for stage III colon cancer in the French settingJ Y Douillard, P Tilleul, M Ychou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Ondansetron Delayed Emesis Study GroupI Olver, W Paska, A Depierre, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 30, 2011
Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancerX B D'Journo, M Ouattara, A Loundou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancerM Ducreux, M Ychou, J F Seitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2011
Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacyC Twelves, W Scheithauer, J McKendrick, et al.
Endoscopy|October 26, 1999
Distant lymph node metastases in esophageal cancer: impact of endoscopic ultrasound-guided biopsyM Giovannini, G Monges, J F Seitz, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
Impact of UFT on tumoral TS and DPD levels in colorectal cancerG Bastian, J F Seitz, V Moutardier, et al.
Journal of Molecular Endocrinology|October 1, 1993
Detection of gastrin mRNA in fresh human colonic carcinomas by reverse transcription-polymerase chain reactionG Monges, P Biagini, J F Cantaloube, et al.
Cancer|March 15, 1997
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)C Tournigand, C Louvet, A de Gramont, et al.
Acta Gastroenterologica Latinoamericana|May 29, 1999
[Ecoendoscopy in the assessment of esophageal neoplasms]A Giacoia, P Thomas, M Giovannini, et al.
Pageof 12